$2.00
0.010.50%
Pre-Market: 7:54 AM EDT
15 minutes delayed
Comments
Loading...
Lexicon Pharmaceuticals
LXRXNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock, Analyst Ratings, Price Targets, Forecasts
Lexicon Pharmaceuticals Inc has a consensus price target of $7.2 based on the ratings of 6 analysts. The high is $10 issued by HC Wainwright & Co. on July 16, 2024. The low is $3 issued by Jefferies on March 7, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on July 16, 2024, June 24, 2024, and June 21, 2024, respectively. With an average price target of $10 between HC Wainwright & Co., there's an implied 400.00% upside for Lexicon Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Leerink Partners
Citigroup
Jefferies
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Lexicon Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/16/2024 | Buy Now | 400% | HC Wainwright & Co. | Joseph Pantginis | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 06/24/2024 | Buy Now | 400% | HC Wainwright & Co. | Joseph Pantginis | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2024 | Buy Now | 400% | HC Wainwright & Co. | Joseph Pantginis | → $10 | Reiterates | → Buy | Get Alert |
| 06/17/2024 | Buy Now | 400% | HC Wainwright & Co. | Joseph Pantginis | → $10 | Initiates | → Buy | Get Alert |
| 05/03/2024 | Buy Now | — | Needham | Joseph Stringer | — | Reiterates | → Hold | Get Alert |
| 04/30/2024 | Buy Now | 150% | Leerink Partners | — | → $5 | Initiates | → Outperform | Get Alert |
| 04/23/2024 | Buy Now | — | Needham | Joseph Stringer | — | Reiterates | → Hold | Get Alert |
| 04/11/2024 | Buy Now | — | Needham | Joseph Stringer | — | Reiterates | → Hold | Get Alert |
| 05/31/2023 | Buy Now | 300% | Citigroup | Yigal Nochomovitz | $6 → $8 | Maintains | Buy | Get Alert |
| 05/30/2023 | Buy Now | — | Needham | Joseph Stringer | — | Maintains | Hold | Get Alert |
| 03/07/2023 | Buy Now | 50% | Jefferies | Andrew Tsai | → $3 | Initiates | → Hold | Get Alert |
| 11/22/2022 | Buy Now | 200% | Citigroup | Yigal Nochomovitz | $16 → $6 | Maintains | Buy | Get Alert |
| 08/12/2022 | Buy Now | 400% | Piper Sandler | Yasmeen Rahimi | → $10 | Initiates | → Overweight | Get Alert |
| 07/01/2022 | Buy Now | 900% | Citigroup | Yigal Nochomovitz | $18 → $20 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Lexicon Pharmaceuticals (LXRX) stock?
The latest price target for Lexicon Pharmaceuticals (NASDAQ:LXRX) was reported by HC Wainwright & Co. on July 16, 2024. The analyst firm set a price target for $10.00 expecting LXRX to rise to within 12 months (a possible 400.00% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Lexicon Pharmaceuticals (LXRX)?
The latest analyst rating for Lexicon Pharmaceuticals (NASDAQ:LXRX) was provided by HC Wainwright & Co., and Lexicon Pharmaceuticals reiterated their buy rating.
When was the last upgrade for Lexicon Pharmaceuticals (LXRX)?
There is no last upgrade for Lexicon Pharmaceuticals
When was the last downgrade for Lexicon Pharmaceuticals (LXRX)?
There is no last downgrade for Lexicon Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Lexicon Pharmaceuticals (LXRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lexicon Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lexicon Pharmaceuticals was filed on July 16, 2024 so you should expect the next rating to be made available sometime around July 16, 2025.
Is the Analyst Rating Lexicon Pharmaceuticals (LXRX) correct?
While ratings are subjective and will change, the latest Lexicon Pharmaceuticals (LXRX) rating was a reiterated with a price target of $10.00 to $10.00. The current price Lexicon Pharmaceuticals (LXRX) is trading at is $2.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.